TYLER BYRD: Open Payments
NPI 1255787636 · HOMEWOOD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 47 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $391 · 2025 $1,061
Food & beverage: $838Education: $223
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $408 |
| Vanda Pharmaceuticals Inc. | 6 | $148 |
| E.R. Squibb & Sons, L.L.C. | 6 | $125 |
| Neurocrine BioSciences, Inc. | 4 | $96 |
| Alkermes, Inc. | 4 | $94 |
| Lundbeck LLC | 4 | $75 |
| Supernus Pharmaceuticals, Inc. | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: UZEDY, FANAPT, COBENFY, INGREZZA, ARISTADA, ABILIFY MAINTENA, Qelbree, SPRAVATO.
Industry payments across AL — which companies pay providers there.
